Gilead Touches Lowest Level Since 2014 Following Q4 Report

Gilead Sciences, Inc. GILD shares are trading lower in Tuesday's after-hours session by $3.13 at $70.00 from Tuesday's closing price of $73.13.

The issue isn't being rewarded for its Q4 beat of $0.11 along with a revenue beat of $116 million. The FY 2017 sales guidance of $22.50-$24.50 million and adjusted EPS of $0.84-$0.91 may not compare with prior estimates.

At the end of Tuesday's session, the issue had cleared the sellers lurking at the $73.00 level, finally pushing through as high as $73.30 before the ending the session at $73.13. The buyers of those shares in that area are now deeply in the red.

In extremely volatile trading, the issue briefly spiked to $75.00 on the initial headlines, but sellers flooded the issue. So far, the ensuing decline has taken the issue to $69.80 and now is trying to remain in the $70.00. The after-market low as of 4:28 p.m. ET coincides with its low for it recent decline that was made on January 24 at $69.78.

Gilead hasn't traded under $70.00 since April 2014.